← Leaderboards
Eileen J Kennedy
University Of Georgia
$1,918,465
Attributed
$1,918,465
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $308.2K · FY2011–22$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,918,465 · 3
By mechanism
R01$1,197,785 · 1
K22$570,680 · 1
R03$150,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Specificity”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Eric S Lander · Whitehead Institute For Biomedical Res$527,312,131
- Barton F Haynes · Duke University$483,626,898
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$395,980,920
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$381,706,339
Research focus
SpecificityDesignPeptidesInsightMediatingSignal TransductionTumorResistanceMalignant NeoplasmsMalignant Breast NeoplasmSurfaceProtein Protein InteractionBaseStructureBiologyAmino AcidsComplexCellsRegulationEventPhenotypeBreast Cancer CellBreastProteins
Grant awards (9)
Targeting WASF3 to suppress metastasis$296,517
R01 · FY2022 · GM · contact PI
Targeting WASF3 to suppress metastasis$296,517
R01 · FY2021 · GM · contact PI
Targeting WASF3 to suppress metastasis$296,517
R01 · FY2020 · GM · contact PI
Targeting WASF3 to suppress metastasis$308,234
R01 · FY2019 · GM · contact PI
Targeted Inhibition of EGFR Dimerization$75,000
R03 · FY2016 · CA · contact PI
Targeted Inhibition of EGFR Dimerization$75,000
R03 · FY2015 · CA · contact PI
Probing the role of AKAPs in breast cancer using stapled peptide inhibitors$191,160
K22 · FY2013 · CA · contact PI
Probing the role of AKAPs in breast cancer using stapled peptide inhibitors$191,160
K22 · FY2012 · CA · contact PI
Probing the role of AKAPs in breast cancer using stapled peptide inhibitors$188,360
K22 · FY2011 · CA · contact PI